Epigenetics Market

Epigenetics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

# Pages:

140

Base Year:

2022

Feb - 2022

Format:

Report Code:

VMR-1339

Segments Covered

By Product Instruments, Reagents & Kits, Others
By Application Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases, Others
By Technology Methylation, Acetylation, Phosphorylation, Other Technologies
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 1.9 Billion
Revenue 2030:	USD 4.41 Billion
Revenue CAGR (2023 - 2030):	12.80%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Epigenetics Market - Segment Analysis
1. Overview
2. Global Epigenetics Market, 2016 - 2028 (USD Million)
3. Global Epigenetics Market - by Product
  1. By Instruments
  2. By Reagents & Kits
  3. By Others
4. Global Epigenetics Market - by Application
  1. By Oncology
  2. By Autoimmune Diseases
  3. By Metabolic Diseases
  4. By CNS/Pain Diseases
  5. By Cardiovascular Diseases
  6. By Others
5. Global Epigenetics Market - by Technology
  1. By Methylation
  2. By Acetylation
  3. By Phosphorylation
  4. By Other Technologies
6. Global Epigenetics Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Epigenetics Market - Segment Analysis
1. Overview
2. North America Epigenetics Market, 2016 - 2028 (USD Million)
3. North America Epigenetics Market, by Product
  1. By Instruments
  2. By Reagents & Kits
  3. By Others
4. North America Epigenetics Market, by Application
  1. By Oncology
  2. By Autoimmune Diseases
  3. By Metabolic Diseases
  4. By CNS/Pain Diseases
  5. By Cardiovascular Diseases
  6. By Others
5. North America Epigenetics Market, by Technology
  1. By Methylation
  2. By Acetylation
  3. By Phosphorylation
  4. By Other Technologies
6. North America Epigenetics Market, by Country
  1. U.S.
    1. U.S. Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. U.S. Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. U.S. Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  2. Canada
    1. Canada Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Canada Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Canada Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  3. Mexico
    1. Mexico Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Mexico Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Mexico Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
Europe Epigenetics Market - Segment Analysis
1. Overview
2. Europe Epigenetics Market, 2016 - 2028 (USD Million)
3. Europe Epigenetics Market, by Product
  1. By Instruments
  2. By Reagents & Kits
  3. By Others
4. Europe Epigenetics Market, by Application
  1. By Oncology
  2. By Autoimmune Diseases
  3. By Metabolic Diseases
  4. By CNS/Pain Diseases
  5. By Cardiovascular Diseases
  6. By Others
5. Europe Epigenetics Market, by Technology
  1. By Methylation
  2. By Acetylation
  3. By Phosphorylation
  4. By Other Technologies
6. Europe Epigenetics Market, by Country
  1. Germany
    1. Germany Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Germany Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Germany Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  2. UK
    1. UK Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. UK Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. UK Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  3. France
    1. France Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. France Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. France Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  4. Spain
    1. Spain Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Spain Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Spain Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  5. Italy
    1. Italy Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Italy Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Italy Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  6. BENELUX
    1. BENELUX Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. BENELUX Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. BENELUX Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  7. Rest of Europe
    1. Rest Of Europe Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Rest Of Europe Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Rest Of Europe Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
Asia Pacific Epigenetics Market - Segment Analysis
1. Overview
2. Asia Pacific Epigenetics Market, 2016 - 2028 (USD Million)
3. Asia Pacific Epigenetics Market, by Product
  1. By Instruments
  2. By Reagents & Kits
  3. By Others
4. Asia Pacific Epigenetics Market, by Application
  1. By Oncology
  2. By Autoimmune Diseases
  3. By Metabolic Diseases
  4. By CNS/Pain Diseases
  5. By Cardiovascular Diseases
  6. By Others
5. Asia Pacific Epigenetics Market, by Technology
  1. By Methylation
  2. By Acetylation
  3. By Phosphorylation
  4. By Other Technologies
6. Asia Pacific Epigenetics Market, by Country
  1. China
    1. China Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. China Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. China Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  2. Japan
    1. Japan Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Japan Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Japan Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  3. India
    1. India Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. India Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. India Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  4. South Korea
    1. South Korea Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. South Korea Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. South Korea Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  5. South East Asia
    1. South East Asia Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. South East Asia Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. South East Asia Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Rest of Asia Pacific Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Rest of Asia Pacific Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
Latin America Epigenetics Market - Segment Analysis
1. Overview
2. Latin America Epigenetics Market, 2016 - 2028 (USD Million)
3. Latin America Epigenetics Market, by Product
  1. By Instruments
  2. By Reagents & Kits
  3. By Others
4. Latin America Epigenetics Market, by Application
  1. By Oncology
  2. By Autoimmune Diseases
  3. By Metabolic Diseases
  4. By CNS/Pain Diseases
  5. By Cardiovascular Diseases
  6. By Others
5. Latin America Epigenetics Market, by Technology
  1. By Methylation
  2. By Acetylation
  3. By Phosphorylation
  4. By Other Technologies
6. Latin America Epigenetics Market, by Country
  1. Brazil
    1. Brazil Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Brazil Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Brazil Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  2. Argentina
    1. Argentina Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Argentina Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Argentina Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  3. Rest of Latin America
    1. Rest of Latin America Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Rest of Latin America Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Rest of Latin America Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
Middle East & Africa Epigenetics Market - Segment Analysis
1. Overview
2. Middle East & Africa Epigenetics Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Epigenetics Market, by Product
  1. By Instruments
  2. By Reagents & Kits
  3. By Others
4. Middle East & Africa Epigenetics Market, by Application
  1. By Oncology
  2. By Autoimmune Diseases
  3. By Metabolic Diseases
  4. By CNS/Pain Diseases
  5. By Cardiovascular Diseases
  6. By Others
5. Middle East & Africa Epigenetics Market, by Technology
  1. By Methylation
  2. By Acetylation
  3. By Phosphorylation
  4. By Other Technologies
6. Middle East & Africa Epigenetics Market, by Country
  1. GCC Countries
    1. GCC Countries Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. GCC Countries Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. GCC Countries Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  2. South Africa
    1. South Africa Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. South Africa Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. South Africa Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Epigenetics Market, By Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    2. Rest of Middle East & Africa Epigenetics Market, By Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    3. Rest of Middle East & Africa Epigenetics Market, By Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Illumina (US)
2. Thermo Fisher Scientific (US)
3. Merck Millipore (US)
4. Abcam (UK)
5. Active Motif (US)
6. Bio-Rad Laboratories (US)
7. New England Biolabs (US)
8. Agilent (US)
9. QIAGEN (Netherlands)
10. Zymo Research (US)
11. PerkinElmer (US)
12. and Diagenode (Belgium) are the major companies operating in Epigenetics Market.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 24-Feb-2022

Epigenetics Market to Reach Valuation of USD 3.0 Billion by 2028 - Increasing Technological Advancements in the Healthcare Sector is Driving the Market

FAQ

Frequently Asked Question

What is the global demand for Epigenetics in terms of revenue?

The global Epigenetics valued at USD 1.9 Billion in 2022 and is expected to reach USD 4.41 Billion in 2030 growing at a CAGR of 12.80%.

Which are the prominent players in the market?

The prominent players in the market are Illumina (US), Thermo Fisher Scientific (US), Merck Millipore (US), Abcam (UK), Active Motif (US), Bio-Rad Laboratories (US), New England Biolabs (US), Agilent (US), QIAGEN (Netherlands), Zymo Research (US), PerkinElmer (US), and Diagenode (Belgium) are the major companies operating in Epigenetics Market..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 12.80% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Epigenetics include
- Rising Cancer Prevalence

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Epigenetics in 2022.

Epigenetics Market

Epigenetics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Epigenetics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Epigenetics Market

Epigenetics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Epigenetics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Epigenetics Market

Vantage Point Interactive Dashboard